RadNet (RDNT) Q2 2026: 25% Revenue Growth Driven by Advanced Imaging and Digital Health Expansion
RadNet posted record quarterly revenue and adjusted EBITDA, fueled by a 21% surge in advanced imaging volumes and robust Digital Health segment growth. Strategic investments in AI-powered workflow solutions are enhancing operational efficiency amid labor shortages. Upward guidance revisions underscore confidence in sustained expansion and margin improvement.
Summary
- Advanced Imaging Capacity Expansion: Significant volume growth driven by faster MRI scanners and remote technologist support.
- Digital Health Momentum: Nearly doubled annual recurring revenue with expanding external customer base and AI integration.
- Strategic Capital Deployment: Opportunistic debt repricing and increased credit facility to fund acquisitions and organic growth.
Business Overview
RadNet is a leading national provider of fixed-site outpatient diagnostic imaging services in the United States, operating 442 owned and joint venture imaging centers. The company generates revenue primarily through procedural imaging services and digital health solutions, segmented into Imaging Centers and Digital Health. The Imaging Centers focus on MRI, CT, PET/CT, and routine imaging modalities, while Digital Health delivers AI-powered radiology information technology and enterprise imaging solutions under the DeepHealth brand.
Performance Analysis
RadNet achieved a 25% year-over-year increase in total company revenue to $622.7 million in Q2 2026, alongside a 22.7% rise in adjusted EBITDA to $99.7 million, both quarterly records. The Imaging Center segment benefited from a 21.2% increase in aggregate advanced imaging procedural volumes, notably with MRI, CT, and PET/CT volumes growing by 21%, 20.9%, and 31% respectively. This volume surge, coupled with operational enhancements such as the adoption of faster MRI scanners and TechLive remote technologist staffing, contributed to a 17 basis point improvement in adjusted EBITDA margin to 16.1%.
The Digital Health segment posted a 56.5% revenue increase to $32.4 million, driven by AI and enterprise imaging solutions. Annual Recurring Revenue (ARR) nearly doubled to $105.5 million, with 63% generated from external customers. Despite margin dilution from growth investments and acquisitions, the segment’s adjusted EBITDA showed sequential improvement. The company’s strategic deployment of FDA-cleared AI tools, including breast ultrasound and thyroid ultrasound draft reporting, is enhancing radiologist productivity and patient throughput.
- Volume Growth Levers: Capacity expansion through capital equipment upgrades and extended scanning hours.
- Digital Health Integration: Successful acquisition integrations and expansion of AI-powered reporting solutions.
- Margin Dynamics: Wage inflation pressures partially offset by operational efficiencies and cost synergies from acquisitions.
Overall, RadNet’s financial health remains robust with $726 million in cash and a net debt to adjusted EBITDA ratio of 1.8x, supporting continued investment in growth initiatives.
Executive Commentary
"The Imaging Center and Digital Health reportable operating segments continue to demonstrate strong growth and achieve record quarterly results... Growth was driven by strong increases in aggregate and same center procedural volumes, the contribution from recent acquisitions, a continuing shift in procedural volumes towards advanced imaging and incremental Digital Health sales and licenses of Enterprise Imaging and AI solutions."
Dr. Howard Berger, President and Chief Executive Officer
"Digital health revenue for the quarter was $32.4 million, up 56.5% year-over-year... Our clinical AI and enterprise imaging TCV funnel has grown from roughly $101 million at the start of the year to more than $224 million in TCV... We remain on track to meet our guidance for the year, the 10 to 12 million adjusted EBITDA, and from there onwards move towards 20% plus margins."
Case Westdorp, President and CEO, Digital Health
Strategic Positioning
1. Advanced Imaging Capacity and Workflow Innovation
RadNet is aggressively expanding advanced imaging capacity through investments in faster MRI scanners, extended operating hours, and TechLive remote technologist staffing. These initiatives address industry-wide labor shortages and enable the company to capture growing demand for complex imaging procedures such as PSMA prostate and brain amyloid PET-CT scans. The strategic focus on operational efficiency is critical to sustaining margin expansion despite wage inflation pressures.
2. Digital Health Platform as a Growth Engine
The Digital Health segment is scaling rapidly, underpinned by a diversified portfolio of FDA-cleared AI solutions and enterprise imaging products. Nearly two-thirds of ARR is sourced from external customers, signaling successful market penetration beyond RadNet’s own imaging centers. Integration of recent acquisitions like Gleamer has advanced the company’s AI capabilities and contributed to a growing sales funnel exceeding $220 million in total contract value, positioning the segment for accelerated margin expansion.
3. Health System Partnerships and Joint Ventures
With 36% of centers held in health system partnerships, RadNet is deepening collaborations that leverage its outpatient imaging expertise and digital health tools. The recent multi-site joint venture with Trinity Health’s Saint Alphonsus Health System exemplifies this strategy, integrating DeepHealth AI solutions to enhance diagnostic accuracy and operational productivity. These partnerships address hospital radiology staffing challenges and create cross-selling opportunities for RadNet’s technology offerings.
4. Capital Structure Optimization and Acquisition Strategy
RadNet opportunistically repriced its debt, reducing interest costs by 25 basis points, and expanded its term loan by $250 million to fund ongoing acquisitions and organic growth. The company’s disciplined capital allocation balances tuck-in acquisitions in Digital Health and Imaging Centers with investments in de novo facility development. This financial flexibility supports RadNet’s consolidation strategy in a fragmented outpatient imaging market.
5. AI-Driven Radiology Workflow Transformation
RadNet is pioneering AI-powered draft reporting solutions that automate lesion detection and reporting in modalities such as ultrasound and x-ray. Early deployments have demonstrated radiologist acceptance rates exceeding 90%, with potential to reduce sonographer scan times by up to one-third. The company targets 15% of volumes processed by AI draft reporting by year-end 2026 and aims to exceed 50% by mid-2027, unlocking significant productivity gains amid radiologist shortages.
Key Considerations
RadNet’s second quarter results reflect a successful execution of its dual-segment growth strategy, leveraging technological innovation and capacity expansion to capture rising demand for advanced imaging and AI-driven solutions.
Key Considerations:
- Labor Market Constraints: Persistent shortages of radiologists and technologists drive the need for AI automation and remote staffing solutions.
- Reimbursement Environment: Medicare proposals suggest near-neutral reimbursement impact in 2027, with site neutrality provisions likely to pressure hospital outpatient imaging economics, benefiting RadNet’s outpatient model.
- Integration Costs: Margin dilution from recent acquisitions and platform integrations is expected to abate in the second half of 2026.
- Regulatory Approvals and Reimbursement Codes: FDA clearance of breast ultrasound AI and associated CPT codes underpin revenue growth and cost savings in Digital Health.
- Health System Partnership Pipeline: Growing inbound interest from hospitals seeking outpatient imaging partnerships and AI tools highlights a strategic growth vector.
Risks
RadNet faces execution risks related to the integration of acquisitions and scaling of AI solutions, as well as ongoing wage inflation pressures that could compress margins. Regulatory changes or delays in reimbursement approvals may impact Digital Health revenue growth. The competitive landscape in outpatient imaging and digital health is intensifying, requiring sustained innovation and capital deployment.
Forward Outlook
For Q3 2026, RadNet anticipates continued growth supported by new contract implementations and operational efficiencies. The company has raised full-year 2026 guidance for the Imaging Center segment to $2.37 billion to $2.42 billion in revenue and $345 million to $358 million in adjusted EBITDA. Free cash flow guidance also increased to $115 million to $125 million. Digital Health revenue and adjusted EBITDA guidance remain unchanged, with expectations to exceed $140 million in ARR by year-end 2026 and progress toward 20% plus segment margins by 2028.
Takeaways
RadNet’s Q2 2026 performance highlights the successful scaling of advanced imaging volumes and Digital Health solutions amid a challenging labor environment and evolving reimbursement landscape.
- Operational Leverage Through AI: The deployment of AI-powered draft reporting and remote technologist staffing is materially enhancing capacity and efficiency, addressing critical labor shortages.
- Robust Digital Health Growth: Nearly doubling ARR and expanding external customer penetration validate RadNet’s strategy to transform radiology workflows and generate recurring revenue streams.
- Capital Position Enables Growth: Opportunistic debt repricing and increased credit availability provide the financial flexibility to pursue acquisitions and organic expansion in a consolidating market.
Conclusion
RadNet’s Q2 results demonstrate a strong operational and strategic execution, positioning the company to capitalize on growing demand for advanced imaging and AI-driven radiology solutions. The upward revisions to guidance and sustained investment in technology and partnerships support a positive medium-term outlook.
Industry Read-Through
RadNet’s success in expanding advanced imaging capacity and digitally transforming radiology workflows underscores the broader healthcare trend toward outpatient imaging and AI adoption. The company’s experience with FDA-cleared AI tools and reimbursement code integration provides a blueprint for peers navigating similar labor constraints and technological shifts. Additionally, the growing pressure on hospital radiology departments, driven by site neutrality reimbursement changes and staffing shortages, is likely to accelerate the outpatient imaging market consolidation and digital health partnerships across the sector.